Health stock Park Medi World jumps 10% despite stock market crash. Emkay sees over 25% more upside (opens original article in a new tab)

Park Medi World shares rose 10% despite a broader market downturn, as Emkay Research upgraded its rating and forecasted significant growth potential for the healthcare company.

• Park Medi World shares jumped 10% after Emkay Research gave a 'Buy' rating and set a target price of ₹350, implying 35% upside
• Emkay highlighted Park Medi World's strong business model, low capital expenditure, and successful acquisition-led expansion strategy
• The brokerage forecasts 24% revenue CAGR and 23% EBITDA CAGR between FY26 and FY29, driven by expansion and operational improvements
• Valence: 2
• tldr:
• Park Medi World shares rose 10% despite a broader market downturn, as Emkay Research upgraded its rating and forecasted significant growth potential for the healthcare company.